The Cannaisseur Group, Inc.

TCRG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $0 $0 $0 $0 $0 $0 $0 $285
Cost of Revenue $118 $0 $192 $272 $282 $164 $1.1K $668
Gross Profit $-118 $0 $-192 $-272 $-282 $-164 $-1.1K $-383
Gross Margin -134.4%
Operating Expenses
Research & Development
SG&A Expense $94.7K $102.3K $101.2K $690.2K $77.2K $846.9K $88.3K $21.0K
Operating Income $-94.8K $-102.3K $-101.4K $-690.5K $-77.5K $-847.1K $-89.4K $-21.3K
Operating Margin -7,486.3%
Interest Expense
Pretax Income $-95.1K $-102.5K $-101.6K $-778.8K $-79.1K $-848.8K $-91.1K $-23.0K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income $-94.9K $-102.4K $-101.4K $-745.2K $-78.7K $-848.6K $-1.3M $-22.3K
Net Margin -7,836.1%
EPS (Basic) $0.00 $0.00 $0.00 $-0.01 $0.00 $-0.02 $-0.01 $0.00
EPS (Diluted) $0.00 $0.00 $0.00 $-0.01 $0.00 $-0.02 $-0.01 $0.00
Shares Outstanding (Basic) 60.5M 60.4M 53.9M 57.2M 49.9M 47.9M 43.8M 44.2M
Shares Outstanding (Diluted) 60.5M 60.4M 53.9M 57.2M 49.9M 47.9M 43.8M 44.2M
Dividends Per Share
← Newer Page 1 of 2 Older →